Interferon treatment for dilated cardiomyopathy and striated myopathy associated with hepatitis C virus infection based on serial measurements of serum concentrations of cardiac troponin T

Japanese Circulation Journal

Volumn 64, Issue 4, 2000, Pages 321-324

  Sato, Yukihito ^a   Takatsu, Yoshiki ^a   Yamada, Tasuku ^a   Kataoka, Kazuaki ^a   Taniguchi, Ryoji ^a   Mimura, Rokuro ^a   Sasayama, Shigetake ^b   Matsumori, Akira ^b  

^a HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Dilated cardiomyopathy; Heart failure; Hepatitis C; Interferon; Troponin T

Indexed keywords

INTERFERON; TROPONIN T;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; HEART DILATATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART VENTRICULOGRAPHY; HEPATITIS C; HUMAN; MUSCLE DISEASE; PATHOGENESIS; POLYMERASE CHAIN REACTION; QUADRICEPS FEMORIS MUSCLE; VIRUS INFECTION;

ANTIVIRAL AGENTS; CARDIOMYOPATHY, DILATED; FEMALE; HEPATITIS C; HUMANS; INTERFERONS; MIDDLE AGED; MUSCULAR DISEASES; TROPONIN T;

EID: 0034120504     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.64.321     Document Type: Article

References (17)

1. Matsumori A, Matoba Y, Sasayama S: Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation 1995; 92: 2519-2525
2. Matsumori A, Matoba Y, Nishio R, Shioi T, Ono K, Sasayama S: Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy. Biochem Biophys Res Commun 1996; 222: 678-682
3. Matsumori A, Ohashi N, Hasegawa K, Sasayama S, Eto T, Imaizumi T, et al: Hepatitis C virus infection and heart diseases: A multicenter study in Japan. Jpn Circ J 1998; 62: 389-391
4. Matsumori A, Ohashi N, Sasayama S: Hepatitis C virus infection and hypertrophic cardiomyopathy. Ann Intern Med 1998; 129: 749-750
5. Matsumori A: Molecular and immune mechanisms in the pathogenesis of cardiomyopathy: Role of viruses, cytokines, and nitric oxide. Jpn Circ J 1997; 61: 275-291
6. Matsumori A, Ohashi N, Nishio R, Kakio T, Hara M, Furukawa Y, et al: Apical hypertrophic cardiomyopathy and hepatitis C viras infection. Jpn Circ J 1999; 63: 433-438
7. Sato Y, Kataoka K, Matsumori A, Sasayama S, Yamada T, Ito H, et al: Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy. Heart 1997; 78: 505-508
8. Sato Y, Yamada T, Taniguchi R, Kataoka K, Sasayama S, Matsumori A, et al: Serum concentration of cardiac troponin T in patients with cardiomyopathy: A possible mechanism of acute heart failure (Letter). Heart 1998; 80: 209-210
9. Sato Y, Taniguchi R, Yamada T, Nagai K, Makiyama T, Okada H, et al: Measurements of serum concentrations of cardiac troponin T in patients with hypereosinophilic syndrome: A sensitive non-invasive marker of cardiac disorder (Letter). Intern Med (in press)
10. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, et al: Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial. N Engl J Med 1989; 321: 1501-1506
11. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, et al: Recombinant interferon alfa therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial. N Engl J Med 1989; 321: 1506-1510
12. Matsumori A, Crumpacker CS, Abelmann WH: Prevention of viral myocarditis with recombinant human leukocyte interferon alfa A/D in murine model. J Am Coll Cardiol 1987; 9: 1320-1325
13. Sonnenblick M, Rosin A: Cardiotoxicity of interferon: A review of 44 cases. Chest 1991; 99: 557-561
14. Okabe M, Fukuda K, Arakawa K, Kikuchi M: Chronic variant of myocarditis associated with hepatitis C virus infection. Circulation 1997; 96: 22-24
15. Arai H, Tanaka M, Ohta K, Kojo T, Niijima K, Imawari M: Symptomatic myopathy associated with interferon therapy for chronic hepatitis C (Letter). Lancet 1995; 345: 582
16. Horsmans Y, Geubel AP: Symptomatic myopathy in hepatitis C infection without interferon therapy (Letter). Lancet 1995; 345: 1236
17. Ueno Y, Kondo K, Kidokoro N, Kobashi R, Kanaji K, Matsumura T: Hepatitis C infection and polymyositis (Letter). Lancet 1995; 346: 319-20